20-Jul-2008

• » Trading Statement

London, 19 July 2008: Hikma Pharmaceuticals PLC (“Hikma”) (LSE:HIK)(DIFX:HIK) today comments on trading in the six months to 30 June 2008.

In the first half of 2008, our Branded business performed ahead of our expectations, with strong sales growth boosted by the smooth integration of the acquisitions made in the second half of 2007. Our Injectables business also performed well, delivering strong sales growth for the period.

• » Download Annual Report 2007 (PDF, 2MB)

• » View all annual reports